吸烟者及慢阻肺患者肺泡与支气管上皮ACE2表达增加
本研究在大量表型明确的肺组织标本中检测ACE2的mRNA和蛋白表达,涵盖从不吸烟者、无气流受限的当前吸烟者及慢阻肺患者。结果显示吸烟者和慢阻肺患者肺泡与支气管上皮ACE2蛋白水平增高,可能促进SARS-CoV-2进入宿主细胞。
要点
- 吸烟者及慢阻肺患者肺泡和支气管上皮ACE2蛋白表达增高。
- ACE2是SARS-CoV-2的细胞进入受体。
- 该发现可能部分解释吸烟者和慢阻肺患者COVID-19重症风险更高。
核心结论
- 吸烟者和慢阻肺患者肺泡与支气管上皮ACE2蛋白水平增高,可能促进SARS-CoV-2进入宿主细胞。
研究设计与样本
- 研究检测了大量表型明确的肺组织标本中ACE2的mRNA和蛋白表达,包括从不吸烟者、无气流受限的当前吸烟者和慢阻肺患者。
主要发现
- 吸烟者和慢阻肺患者肺泡上皮ACE2蛋白水平增高。
- 吸烟者和慢阻肺患者支气管上皮ACE2蛋白水平增高。
临床怎么用
- 对吸烟者和慢阻肺患者应重视SARS-CoV-2感染的预防与早期识别。
- 该机制提示此类人群感染后重症风险可能更高,需加强临床监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study demonstrates increased protein levels of ACE2 in alveolar and bronchial epithelium of smokers and subjects with COPD, which might facilitate host cell entry of SARS-CoV-2 https://bit.ly/2ZazOrd Angiotensin-converting enzyme 2 (ACE2) has been identified as the cell entry receptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1, 2]. Importantly, smokers and patients with COPD are at an increased risk of severe complications and a higher mortality upon SARS-CoV-2 infection [3]. We hypothesised that ACE2 expression is increased in lungs of smokers and patients with COPD, which may at least partially explain their higher risk of a more severe course of coronavirus disease 2019 (COVID-19). Therefore, we aimed to investigate the expression of ACE2 on both mRNA and protein level in a large number of lung tissue specimens of well-phenotyped subjects, including never-smokers, current smokers without airflow limitation, and patients with COPD.
引用
- Jacobs M, Van Eeckhoutte HP, Wijnant SRA, et al. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects. Eur Respir J. 2020. PMID: 32675207. doi:10.1183/13993003.02378-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。